|
SciClone Pharmaceuticals, Inc. - sciclone.com
Develops and markets products targeted for treatment of cancer and diseases such as hepatitis B and C, cystic fibrosis and immune system disorders. Based in San Mateo, California. (Nasdaq: SCLN)
hepatitis hepatitis c hepatitis b hep c hep b zadaxin thymosin thymosin alpha 1 thymalfasin hbv hcv cirrhosis melanoma peg interferon pegylated interferon hcc hepatocellular carcinoma liver cancer
|
